Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock (Q28575608)
Jump to navigation
Jump to search
scientific journal article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock |
scientific journal article |
Statements
2 references
Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock (English)
2 references
Giovanna Piraino
2 references
Prajakta Mangeshkar
2 references
Alvin Denenberg
2 references
Basilia Zingarelli
2 references
Ranjit S Chima
1 October 2008
2 references
2 references
36
2 references
10
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references